2022 annual financial data
Addex Therapeutics 2022 Operating margin
Direct answer
Operating margin was -741.04%.
Operating income was -10,540,901 CHF and net income was -20,804,213 CHF.
Operating cash flow was -16,437,185 CHF.
Get free Addex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,422,438 CHF
- Operating income
- -10,540,901 CHF
- Net income
- -20,804,213 CHF
- Operating cash flow
- -16,437,185 CHF